Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 297

1.

Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.

Brunello A, Basso U, Rossi E, Stefani M, Ghiotto C, Marino D, Crivellari G, Monfardini S.

Drugs Aging. 2007;24(11):967-73.

PMID:
17953463
[PubMed - indexed for MEDLINE]
2.

[Ifosfamide induced encephalopathy: 15 observations].

Dufour C, Grill J, Sabouraud P, Behar C, Munzer M, Motte J, Oberlin O, Paci A, Hartmann O.

Arch Pediatr. 2006 Feb;13(2):140-5. Epub 2005 Dec 20. French.

PMID:
16364615
[PubMed - indexed for MEDLINE]
3.

Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.

Giovanis P, Garna A, Marcante M, Nardi K, Giusto M.

Tumori. 2009 Jul-Aug;95(4):545-6.

PMID:
19856674
[PubMed - indexed for MEDLINE]
4.

Ifosfamide-induced encephalopathy in patients with uterine sarcoma.

Liu YL, Tsai SH, Chang FW, Yu MH.

Taiwan J Obstet Gynecol. 2010 Mar;49(1):77-80. doi: 10.1016/S1028-4559(10)60014-9.

PMID:
20466298
[PubMed - indexed for MEDLINE]
5.

Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Sweiss KI, Beri R, Shord SS.

Drug Saf. 2008;31(11):989-96. Review.

PMID:
18840018
[PubMed - indexed for MEDLINE]
6.

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prové A, Vermorken JB.

Br J Cancer. 2000 Jan;82(2):291-4. Review.

PMID:
10646879
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evaluating risk factors for the development of ifosfamide encephalopathy.

David KA, Picus J.

Am J Clin Oncol. 2005 Jun;28(3):277-80. Review.

PMID:
15923801
[PubMed - indexed for MEDLINE]
8.

Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.

Bernard PA, McCabe T, Bayliff S, Hayes D Jr.

J Oncol Pharm Pract. 2010 Dec;16(4):262-5. doi: 10.1177/1078155209360074. Epub 2010 Jan 29.

PMID:
20118215
[PubMed - indexed for MEDLINE]
9.

Methylene blue for management of Ifosfamide-induced encephalopathy.

Patel PN.

Ann Pharmacother. 2006 Feb;40(2):299-303. Epub 2006 Jan 3. Review.

PMID:
16391008
[PubMed - indexed for MEDLINE]
10.

Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.

Turner AR, Duong CD, Good DJ.

Clin Oncol (R Coll Radiol). 2003 Oct;15(7):435-9.

PMID:
14570094
[PubMed - indexed for MEDLINE]
11.

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.

Howell JE, Szabatura AH, Hatfield Seung A, Nesbit SA.

J Oncol Pharm Pract. 2008 Sep;14(3):157-62. doi: 10.1177/1078155208093930.

PMID:
18719071
[PubMed - indexed for MEDLINE]
12.

Severe ifosfamide-induced neurotoxicity: a case report.

Ramos Linares S, Breña Atienza J, Cháfer Rudilla M, Ríos Rull P, Cabello Rodríguez A, Merino Alonso J.

Pharm World Sci. 2010 Apr;32(2):109-11. doi: 10.1007/s11096-009-9354-4. Epub 2009 Dec 23.

PMID:
20033290
[PubMed - indexed for MEDLINE]
13.

Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.

Küpfer A, Aeschlimann C, Cerny T.

Eur J Clin Pharmacol. 1996;50(4):249-52.

PMID:
8803513
[PubMed - indexed for MEDLINE]
14.

Role of thiamine in managing ifosfamide-induced encephalopathy.

Hamadani M, Awan F.

J Oncol Pharm Pract. 2006 Dec;12(4):237-9.

PMID:
17156595
[PubMed - indexed for MEDLINE]
15.

Ifosfamide neurotoxicty in a young female with a remarkable response to thiamine.

Imtiaz S, Muzaffar N.

J Pak Med Assoc. 2010 Oct;60(10):867-9.

PMID:
21381624
[PubMed - indexed for MEDLINE]
16.

Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors.

Tajino T, Kikuchi S, Yamada H, Takeda A, Konno S.

J Orthop Sci. 2010 Jan;15(1):104-11. doi: 10.1007/s00776-009-1431-y. Epub 2010 Feb 12.

PMID:
20151259
[PubMed - indexed for MEDLINE]
17.

Ifosfamide neuropsychiatric toxicity in patients with cancer.

Alici-Evcimen Y, Breitbart WS.

Psychooncology. 2007 Oct;16(10):956-60. Review.

PMID:
17278152
[PubMed - indexed for MEDLINE]
18.

Ifosfamide encephalopathy.

Ajithkumar T, Parkinson C, Shamshad F, Murray P.

Clin Oncol (R Coll Radiol). 2007 Mar;19(2):108-14. Review.

PMID:
17355105
[PubMed - indexed for MEDLINE]
19.

[Treatment of ifosfamide induced encephalopathy with methylene-blue].

Ferrero JM, Eftekari P, Largillier R, Dreyfus G, Namer M.

Bull Cancer. 1995 Jul;82(7):598-9. French.

PMID:
7549123
[PubMed - indexed for MEDLINE]
20.

Incidence and severity of ifosfamide-induced encephalopathy.

Rieger C, Fiegl M, Tischer J, Ostermann H, Schiel X.

Anticancer Drugs. 2004 Apr;15(4):347-50.

PMID:
15057138
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk